Daily News

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Charles River Laboratories slashed its outlook for 2024 due to light pharma demand, and CRL stock plummeted in early trades. The post Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 appeared first on Investor's Business Daily.

iShook OpinioniShook Opinion
Aug 7, 2024 - 10:25
 0  12
Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Charles River Laboratories slashed its outlook for 2024 due to light pharma demand, and CRL stock plummeted in early trades.

The post Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 appeared first on Investor's Business Daily.

Read More

Tags:

Previous Article

Using a VPN For Streaming Can Save You Money. Here's How

Next Article

Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales

iShook Opinion
iShook Opinion "iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.

Related Posts

Sennheiser Momentum 3 True Wireless ANC Bluetooth Earbuds Are Just $100 Right Now

Sennheiser Momentum 3 True Wireless ANC Bluetooth Earbu...

iShook Opinion Sep 17, 2024  0  4

Best Savings Rates Today -- APYs Falter Amid Recession Fears, Aug. 8, 2024

Best Savings Rates Today -- APYs Falter Amid Recession ...

iShook Opinion Aug 8, 2024  0  9

Google TV Streamer Integrates Entertainment and Home in a Refreshed Design video

Google TV Streamer Integrates Entertainment and Home in...

iShook Opinion Aug 6, 2024  0  8